Leucine

Leucine

SCHEMBL8995763

CC(C)C[C@H](N)C(=O)O.C[C@@H](O)[C@H](N)C(=O)O.NC(=O)C[C@H](N)C(=O)O.N[C@@H](CO)C(=O)O.N[C@@H](CO)C(=O)O

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 1/20 0.55
SLC1A3 P43003 4/20 0.45
SLC1A2 P43004 4/20 0.45
PDCD1LG2 Q9BQ51 1/20 0.40
CD274 Q9NZQ7 1/20 0.40
SLC1A1 P43005 4/20 0.40
GRIK1 P39086 3/20 0.36
USP2 O75604 1/20 0.35
SLCO1B1 Q9Y6L6 1/20 0.35
GRIA2 P42262 2/20 0.35
GRIA4 P48058 2/20 0.35
GRIK3 Q13003 2/20 0.35
GRIK5 Q16478 2/20 0.35
GRIA1 P42261 1/20 0.35
GRIK2 Q13002 1/20 0.35
LAP3 P28838 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Asparagine SCHEMBL8695387 0.94 PDCD1LG2 (0.44) SLC7A5SLC1A3SLC1A2PDCD1LG2CD274
Asparagine SCHEMBL8695366 0.94 PDCD1LG2 (0.44) SLC7A5SLC1A3SLC1A2PDCD1LG2CD274
Asparagine SCHEMBL27468642 0.88 CD274 (0.40) SLC7A5SLC1A3SLC1A2PDCD1LG2CD274
Asparagine SCHEMBL1964053 0.87 SLC7A5 (0.48) SLC7A5SLC1A3SLC1A2SLC1A1GRIK1
Asparagine SCHEMBL9695773 0.87 SLC7A5 (0.48) SLC7A5SLC1A3SLC1A2SLC1A1GRIK1
Asparagine SCHEMBL1964050 0.87 SLC7A5 (0.48) SLC7A5SLC1A3SLC1A2SLC1A1GRIK1
Asparagine SCHEMBL7763890 0.87 SLC7A5 (0.48) SLC7A5SLC1A3SLC1A2SLC1A1GRIK1
Leucine SCHEMBL2722186 0.86 SLC7A5 (0.60) SLC7A5SLC1A3SLC1A2PDCD1LG2CD274
Glutamine SCHEMBL1403799 0.85 ALOX15 (0.54) SLC7A5SLC1A3SLC1A2PDCD1LG2CD274
Glutamine SCHEMBL1403796 0.85 ALOX15 (0.54) SLC7A5SLC1A3SLC1A2PDCD1LG2CD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0728482-A2 Use of hcp specific compounds to enhance erythropoiesis SMITHKLINE BEECHAM CORPORATION (US) 1996-08-28 EP disclosed
EP-0727211-A1 Use of src SH2 specific compounds to treat a bone resorption disease SMITHKLINE BEECHAM CORPORATION (US) 1996-08-21 EP disclosed